Gainers

  • Xperi Corporation XPER shares climbed 44.5 percent to $18.47 after the company announced a settlement of all litigation against Samsung and reported a new patent license agreement between the two companies. Xperi also raised FY18 and Q4 billings guidance.
  • Nutrisystem, Inc. NTRI gained 28.5 percent to $43.96 after Tiv
  • ity Health, Inc. TVTY announced plans to acquire Nutrisystem for $47 per share in cash and stock.
  • Uxin Limited UXIN shares climbed 22.4 percent to $5.73.
  • NF Energy Saving Corporation NFEC shares rose 19.6 percent to $16.19.
  • Systemax Inc. SYX climbed 19.4 percent to $31.06 after announcing a $6.50 per share special cash dividend.
  • Veritone Inc VERI rose 17.8 percent to $6.63 after receiving an acquisition offer from Apis Capital Management for $10.26 per share in cash.
  • Kiniksa Pharmaceuticals, Ltd. KNSA gained 13.9 percent to $24.60.
  • Axsome Therapeutics, Inc. AXSM rose 13.6 percent to $3.35 after reporting positive outcome of interim analysis of ADVANCE-1 Phase 2/3 trial of AXS-05 in Alzheimer’s disease agitation.
  • Limbach Holdings, Inc. LMB gained 12.3 percent to $4.46.
  • Mitek Systems, Inc. MITK rose 11.3 percent to $9.97 after ASG Technologies increased offer from $10 to $11.50 per share to acquire the company.
  • Wheeler Real Estate Investment Trust, Inc. WHLR shares climbed 11.1 percent to $2.50.
  • BioHiTech Global, Inc. BHTG gained 10.3 percent to $2.9762.
  • DiaMedica Therapeutics Inc. DMAC climbed 9.4 percent to $3.39.
  • Destination Maternity Corporation DEST rose 9.2 percent to $4.18.
  • SilverCrest Metals Inc. SILV surged 8.9 percent to $2.45 after the company reported closing of strategic investment by SSR Mining and exercise of warrants.
  • Aphria Inc. APHA rose 8.8 percent to $5.69 after falling 5.60 percent on Friday.
  • Iovance Biotherapeutics, Inc. IOVA gained 8.2 percent to $9.70.
  • Kratos Defense & Security Solutions, Inc. KTOS shares rose 7.6 percent to $14.68.
  • Ra Pharmaceuticals, Inc. RARX rose 7.5 percent to $17.69 after the company disclosed that its Phase 2 trial of zilucoplan met its primary endpoint and 'key' secondary endpoints.
  • A10 Networks, Inc. ATEN shares gained 7.4 percent to $6.51. DA Davidson upgraded A10 Networks from Neutral to Buy.
  • Johnson Outdoors Inc. JOUT rose 7.3 percent to $66.16.
  • Evelo Biosciences, Inc. EVLO shares surged 7 percent to $9.78.

 

Check out these big penny stock gainers and losers

Losers

  • Tivity Health, Inc. TVTY shares dipped 33.2 percent to $27.12 after the company announced plans to acquire Nutrisystem, Inc. NTRI for $47 per share in cash and stock.
  • MacroGenics, Inc. MGNX fell 24.8 percent to $12.35 after reporting partial clinical hold on MGD009 Phase 1 studies.
  • Axovant Sciences Ltd AXON shares tumbled 24.4 percent to $1.2933 after the company disclosed that it did not meet its primary endpoint for its Phase 2 study of nelotanserin.
  • Smaaash Entertainment Inc. SMSH dropped 21.3 percent to $1.60.
  • AgeX Therapeutics, Inc. AGE dipped 17.6 percent to $4.25.
  • Jupai Holdings Limited JP fell 15.5 percent to $5.08 after dipping 33.66 percent on Friday.
  • Gritstone Oncology, Inc. GRTS shares dipped 13.4 percent to $25.50. Gritstone Oncology disclosed that it is advancing its solid tumor bispecific antibody program into lead optimization phase.
  • Marine Products Corporation MPX dropped 12.8 percent to $19.05. B. Riley FBR downgraded Marine Products from Neutral to Sell and lowered the price target from $19 to $16.
  • Himax Technologies, Inc. HIMX fell 12 percent to $3.29.
  • Emerge Energy Services LP EMES dropped 10.5 percent to $2.2014.
  • Adial Pharmaceuticals, Inc. ADIL shares dropped 10.1 percent to $2.14.
  • Navistar International Corporation NAV shares declined 9.5 percent to $25.96. Goldman Sachs downgraded Navistar from Neutral to Sell.
  • Sundance Energy Australia Limited SNDE shares tumbled 7.7 percent to $3.26.
  • Oil-Dri Corporation of America ODC fell 7.1 percent to $27.34.
  • Visteon Corporation VC dipped 6.8 percent to $63.00. Goldman Sachs downgraded Visteon from Neutral to Sell.
  • Synlogic, Inc. SYBX fell 6.2 percent to $7.34 after declining 2.73percent on Friday.
Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!